MARKET

VTRO

VTRO

Vitro Biopharma
AMEX
--
0.00
0.00%
Closed
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
Based on the provided financial report articles, I generated the title for the article: "VTRC's Financial Report: Q1 2025 Earnings and Revenue Breakdown" Please note that the title may not be exact, as the provided text does not contain a clear title. However, based on the content, I inferred the title to be related to VTRC's financial report for the first quarter of 2025, including earnings and revenue breakdown.
Press release · 03/20 16:11
Based on the provided financial report articles, I generated the title for the article: "VTRO, Inc. (0000793171) Financial Report: 2023-2024" Please note that the title may not be exact, as the provided text does not contain a clear title. However, based on the content, I inferred the title to be related to the financial report of VTRO, Inc. (0000793171) covering the period from 2023 to 2024.
Press release · 01/28 20:50
About VTRO
Vitro Biopharma, Inc. is a biotechnology company targeting autoimmune diseases and inflammatory disorders, with an ancillary focus in the research services and cosmeceutical fields. The Company is focused on developing therapeutic products, its stem cell technology, patent portfolio and proprietary technology and cell lines for applications in autoimmune disorders and inflammatory disease processes and stem cell research. The Company is engaged in the development of cellular therapeutic candidates intended to address significant unmet medical needs. In the United States, the Company is authorized to conduct two clinical trials under two Food and Drug Administration (FDA) Investigational New Drug applications to assess the safety and efficacy of AlloRx Stem Cell therapy in PTHS and Long COVID. It is also engaged in various other activities, including providing research services and stem cell products, as well as cosmeceuticals, through its wholly owned subsidiary, namely InfiniVive MD.

Webull offers Vitro Biopharma Inc stock information, including AMEX: VTRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VTRO stock methods without spending real money on the virtual paper trading platform.